PPARGC1A and cancer: Beyond its active role in cancer [27, 34], EVs represent a non-invasive tool that may inform about the molecular alterations in PCa [35], therefore we cannot discard the role of PGC1α-associated EVs as surrogate markers of PGC1α activity and therefore PCa status.